Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 135
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00955110 | Study to Compare Oxymorphone Extended-Release (Opana ER) Versus Oxycodone Controlled-Release (Oxycontin) | ||
| NCT00765323 | Efficacy and Safety Study of Octreotide Implant in Patients With Acromegaly | ||
| NCT04170296 | Real World CCH Study in Adult Females With Cellulite | ||
| NCT01685437 | A Phase 3, Open-label Study of the Safety and Effectiveness of AA4500 Administered Twice Per Treatment Cycle for up to Four Treatment Cycles (2 x 4) in Men With Peyronie's Disease | ||
| NCT02942160 | EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite) | ||
| NCT00574860 | EN3285 for the Prevention or Delay of Oral Mucositis in Patients With Head and Neck Cancer | ||
| NCT01221597 | Study of AA4500 in the Treatment of Peyronie's Disease | ||
| NCT02298829 | Long-term Safety, Curvature Deformity Characterization, and Immunogenicity Over Time in Subjects Previously Treated With AA4500 for Peyronies Disease | ||
| NCT01314664 | A Prospective Registry to Assess the Effectiveness and Local Tolerability of Intravesical Valrubicin in Subjects With Non-muscle Invasive Bladder Cancer (NMIBC) | ||
| NCT00528931 | A Pharmacokinetic Study of AA4500 (XIAFLEX™, Proposed Name) in Subjects With Dupuytren's Contracture | ||
| NCT02193828 | Phase 2a Dose-Ranging Study to Evaluate Safety and Effectiveness of AA4500 in Treatment of Dupuytren's Disease Nodules | ||
| NCT00904475 | Pilot Study of the Efficacy and Safety of Lidoderm Patch in the Treatment of Low Back Pain | ||
| NCT00226421 | Efficacy and Safety of Oxymorphone Extended Release in Opioid-Experienced Patients With Chronic Non-Malignant Pain | ||
| NCT06169319 | A Study to Assess Collagenase Clostridium Histolyticum (CCH) in the Treatment of Plantar Fasciitis (PFA) | ||
| NCT05873595 | Real-World Data Study to Understand Effectiveness of Treatments in Peyronie's Disease | ||
| NCT05152173 | Efficacy, Safety, and Tolerability, of EN3835 vs Placebo in the Treatment of Plantar Fibromatosis | ||
| NCT01715467 | CORRECT: COmmunity RegistRy Study Evaluating Dupuytren's Contracture Treatment | ||
| NCT05254457 | Long-Term Safety, Efficacy, and Durability of EN3835 in the Treatment and Retreatment of Plantar Fibromatosis | ||
| NCT01210352 | Effectiveness, Safety, and Tolerability Study of Oxymorphone Immediate Release (IR) Oral Liquid in Post Surgical Pediatric Subjects | ||
| NCT04209530 | Impact of CCH Treatment of Buttock and Thigh Cellulite in Adult Women | ||
| NCT01784757 | Bioavailability Study of ODM-201 in Subjects With Metastatic Chemotherapy-naive Castration-resistant Prostate Cancer | ||
| NCT06151197 | Study to Assess EN3835 in the Treatment of Plantar Fibromatosis (Also Known as Ledderhose Disease) | ||
| NCT04236635 | Histopathology Following CCH Injection | ||
| NCT00904085 | Post-operative Efficacy and Safety Study | ||
| NCT00904462 | Pilot Study of Lidocaine 5% Patch Versus Placebo in Patients With Osteoarthritis Pain of the Knee | ||
| NCT01013025 | Vantas Implant Retrieval Study | ||
| NCT06649539 | Delayed Dose Collagenase Clostridium Histolyticum (CCH) Protocol for Men With Peyronie's Disease | ||
| NCT00830154 | A Study to Assess the Efficacy and Safety of Pagoclone for Adults With Stuttering | ||
| NCT00755222 | The Safety and Effectiveness of AA4500 in Subjects With Peyronie's Disease | ||
| NCT05777031 | Safety and Efficacy of Collagenase Clostridium Histolyticum After Prior Intralesional PRP for Peyronie's Disease | ||
| NCT01206907 | Effectiveness, Safety, and Tolerability Study of Oxymorphone Immediate Release (IR) Oral Liquid in Opioid Tolerant Pediatric Subjects | ||
| NCT03329989 | Safety and Effectiveness of EN3835 in the Treatment of EFP in Women | ||
| NCT00903851 | Lidoderm® (Lidocaine Patch 5%) in Diabetic and Idiopathic Neuropathy | ||
| NCT01304173 | Retrospective Chart Review of Valstar | ||
| NCT00911261 | Oxymorphone Extended Release in Patients With Cancer or Neuropathic Pain | ||
| NCT01774435 | Study in Stabilized Schizophrenic Patients to Evaluate the Pharmacokinetics of Risperidone and 9-Hydroxy (OH)-Risperidone When Risperidone is Administered From a Polyurethane Implant | ||
| NCT00528424 | AA4500 (XIAFLEX™, Proposed Name) in the Treatment of Advanced Dupuytren's Disease | ||
| NCT04786106 | Investigation of Surgery, Collagenase, and Restorex for the Improvement of Peyronie's | ||
| NCT00913055 | Open Label Study of Octreotide Implant in Patients With Acromegaly | ||
| NCT01310803 | Multi-center Study to Evaluate the Efficacy and Safety of Maintenance Therapy With Valrubicin Versus no Maintenance, in Subjects Treated With Valrubicin Induction for Carcinoma in Situ (CIS) of the Bladder | ||
| NCT04456296 | A Study of the Effect of Testosterone Replacement Therapy on Blood Pressure in Adult Male Participants With Hypogonadism | ||
| NCT01606345 | Phase I Study of Percutaneous Valrubicin for Upper Tract Urothelial Carcinoma | ||
| NCT00260429 | Collagenase in the Treatment of Dupuytrens Disease | ||
| NCT01035983 | Safety and Tolerability of Frovatriptan to Prevention of Menstrually Associated Migraine (MAM) Headaches | ||
| NCT00801398 | Open-Label Safety and Tolerability Study of Oxymorphone for Acute Postoperative Pain in Pediatric Subjects. | ||
| NCT03526549 | Long-Term Study of EN3835 (CCH-aaes) in Edematous Fibrosclerotic Panniculopathy (Cellulite) | ||
| NCT00891163 | Evaluate the Depth and Duration of Anesthesia | ||
| NCT03675685 | Safety and Pharmacokinetics of a Single Dose of CCH (3.36 mg) in Subjects With EFP | ||
| NCT00904449 | Open Label Assessment of Long-Term Safety and Utility | ||
| NCT01518907 | The Safety, Effectiveness, and Pharmacokinetics of AA4500 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite) |
